Bimeda® is pleased to announce Tim Blackstone in the new role of Territory Sales Manager for the Upper Midwest/Plains including the states of North Dakota, South Dakota, Minnesota, and Wisconsin. Tim ...
Bimeda is pleased to announce the launch of Macrosyn (tulathromycin injection) 100mg/mL. Macrosyn is a ready-to-use injectable solution containing 100 mg of tulathromycin/mL, a broad spectrum, fast-ac...
We would like to congratulate Stephanie Batliner, Director of Regulatory Affairs of North America, on her election to the role of Chair of GADA (Generic Animal Drug Alliance). We would like to c...
Following consistent growth and popularity of Bimeda® lnc.'s Confidence EQ®, the parent company announced plans to expand marketing efforts and packaging options today for the equine appeasing ph...
We welcome Dr. Paul Lawrence as the Research and Development Director for Bimeda Biologicals. Dr. Lawrence will manage and provide strategic direction in the development of USDA approved products and ...
Bimeda® is pleased to announce the appointment of David Christian as a Strategic Sales Account Manager for the Livestock Southern Region (Texas, Oklahoma and Eastern New Mexico). David will work as pa...
Bimeda Inc. is pleased to announce the formal renaming of acquired vaccine production, research and diagnostic company, Texas Vet Lab, Inc., as Bimeda Biologicals Inc. Both Texas Vet Lab, Inc. (TVL) a...
Bimeda® is pleased to announce Rey Armendariz in the new role of Regional Strategic Manager. Effective immediately, Rey will be an integral part of the food animal sales team and assist in the sales d...
Oakbrook Terrace, Illinois (May 6, 2020) – Bimeda®, a growing global manufacturer, marketer and distributor of animal health products, announced today their launch of BimaGard™ 12.5% (tiamulin hydroge...
Thank you to Amanda Binneboese, Connie LeVine and Chris Smith from the Bimeda facility in Le Sueur who are sewing washable protective face masks for their fellow colleagues. Bimeda's products pl...